PTPRM: Key Enzyme in Cell Signaling and Growth (G5797)

Target Name: PTPRM

NCBI ID: G5797

PTPRM

PTPRM: Key Enzyme in Cell Signaling and Growth

Protein tyrosine phosphatase (PTPRM), also known as protein tyrosine phosphatase M (PTPM), is a protein that is involved in the regulation of many cellular processes in the body. It is a key enzyme in the PTPM-Tyrosine kinase pathway, which is a pathway that is involved in the regulation of a wide range of cellular processes, including cell signaling, cell growth, and cell death.

PTPRM is a protein that is expressed in many different tissues and cells in the body, including brain, heart, kidney, and liver. It is also a protein that is involved in many different cellular processes, including the regulation of protein kinase activity, the regulation of signaling pathways, and the regulation of cellular signaling pathways.

One of the key functions of PTPRM is its role in the regulation of protein kinase activity. PTPRM is a potent enzyme that can phosphorylate many different protein substrates, including tyrosine, threonine, and serine. This phosphorylation of protein substrates by PTPRM can modulate the activity of many different protein kinases, including tyrosine kinase (TK) kinase, which is involved in the regulation of many different cellular processes.

PTPRM is also involved in the regulation of signaling pathways. For example, it is involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of many different cellular processes, including cell signaling, cell growth, and cell death . In this pathway, PTPRM is involved in the regulation of the activity of the protein kinase Akt, which is a key regulator of many different cellular processes.

In addition to its role in the regulation of protein kinase activity and signaling pathways, PTPRM is also involved in the regulation of cellular signaling pathways. For example, it is involved in the regulation of the JAK/STAT signaling pathway, which is involved in the regulation of many different cellular processes, including cell signaling, cell growth, and cell death. In this pathway, PTPRM is involved in the regulation of the activity of the protein kinase JAK, which is a key regulator of many different cellular processes.

PTPRM is also involved in the regulation of many different cellular processes, including cell signaling, cell growth, and cell death. For example, it is involved in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of many different cellular processes, including inflammation, cell signaling, and cell death. In this pathway, PTPRM is involved in the regulation of the activity of the protein kinase NF-kappa-B, which is a key regulator of many different cellular processes.

In conclusion, PTPRM is a protein that is involved in the regulation of many different cellular processes, including cell signaling, cell growth, and cell death. It is a key enzyme in the PTPM-Tyrosine kinase pathway and is involved in the regulation of protein kinase activity, signaling pathways, and cellular signaling pathways. As a result, PTPRM may be a promising drug target or biomarker for a variety of diseases.

Protein Name: Protein Tyrosine Phosphatase Receptor Type M

Functions: Receptor protein-tyrosine phosphatase that mediates homotypic cell-cell interactions and plays a role in adipogenic differentiation via modulation of p120 catenin/CTNND1 phosphorylation (PubMed:17761881, PubMed:10753936). Promotes CTNND1 dephosphorylation and prevents its cytoplasmic localization where it inhibits SLC2A4 membrane trafficking. In turn, SLC2A4 is directed to the plasma membrane and performs its glucose transporter function (PubMed:21998202)

The "PTPRM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTPRM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets